Celldex Therapeutics reported $1.73B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 270.65B 15.68B
Agenus AGEN:US $ 0.52B 0.11B
Amgen AMGN:US $ 129.97B 0.89B
Applied Genetic Technologies AGTC:US $ 0.05B 0.03B
Aptinyx Inc APTX:US $ 0.04B 0.12B
Biocept BIOC:US $ 0.04B 0.02B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Celldex Therapeutics CLDX:US $ 1.26B 0.33B
Cytrx CYTR:US 0.01B 0.01B
Glaxosmithkline GSK:US 109.29B 0.69B
Immunogen IMGN:US $ 0.99B 0.06B
Merrimack Pharmaceuticals MACK:US $ 0.08B 0B
Nektar Therapeutics NKTR:US $ 0.71B 0.3B
Newlink Genetics NLNK:US $ 0.06B 0.01B
Northwest Biotherapeutics NWBO:US 0.62B 0.05B
Pfizer PFE:US $ 294.18B 1.79B
Rigel Pharmaceuticals RIGL:US $ 0.19B 0.32B
Roche Holding ROG:VX 300.5B 1.25B
Seattle Genetics SGEN:US $ 32.57B 6.12B